Answers are grounded in this paper and cite their sources.
Chronic kidney disease (CKD) is a risk factor for coronary in-stent restenosis (ISR). Drug-coated balloons (DCB) are known to reduce target lesion failure (TLF) compared with conventional balloon angioplasty (BA) in ISR. Little is known, however, regarding the impact of CKD on TLF in patients undergoing DCB treatment for ISR.
No takes yet. Share an insight, caveat, or question.
Vavilin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: